NYSE:OSH Oak Street Health (OSH) Stock Forecast, Price & News Add Compare Share Share Today's Range N/A50-Day Range$34.57▼$39.0052-Week Range N/AVolume2.86 million shsAverage Volume5.76 million shsMarket Capitalization$9.52 billionP/E RatioN/ADividend YieldN/APrice Target$33.27 ProfileProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial MediaSustainabilityProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial MediaSustainability Oak Street Health MarketRank™ ForecastAnalyst RatingHold2.06 Rating ScoreUpside/Downside∞ Upside$33.27 Price TargetShort InterestN/ADividend StrengthN/ASustainability-1.01Upright™ Environmental ScoreNews SentimentN/AInsider TradingSelling Shares$28.40 M Sold Last QuarterProj. Earnings GrowthGrowingFrom ($1.58) to ($1.12) Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.2.07 out of 5 starsMedical Sector925th out of 1,980 stocksHealth Services Industry13th out of 26 stocks 3.0 Analyst's Opinion Consensus RatingOak Street Health has received a consensus rating of Hold. The company's average rating score is 2.06, and is based on 2 buy ratings, 14 hold ratings, and 1 sell rating.Price Target Upside/DownsideAccording to analysts' consensus price target of $33.27, Oak Street Health has a forecasted upside of ∞ from its current price of $0.00.Amount of Analyst CoverageOak Street Health has only been the subject of 2 research reports in the past 90 days. Previous Next N/A Short Interest Short InterestThere is no current short interest data available for OSH. Previous Next 0.0 Dividend Strength Dividend YieldOak Street Health does not currently pay a dividend.Dividend GrowthOak Street Health does not have a long track record of dividend growth. Previous Next 4.4 Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreOak Street Health has received a 66.52% net impact score from Upright. The largest positive contribution comes from its "Physical diseases" impact, which is false driven by its "Private general practice doctor's diagnostic face-to-face appointments", "Private individual preventive healthcare", and "Physical retail of pharmaceuticals at a pharmacy" products. See details.Environmental SustainabilityThe Environmental Impact score for Oak Street Health is -1.01. Previous Next 0.6 News and Social Media Coverage News Coverage This WeekMarketBeat has tracked 1 news article for Oak Street Health this week, compared to 3 articles on an average week.Search Interest1 people have searched for OSH on MarketBeat in the last 30 days. Previous Next 3.3 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Oak Street Health insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $28,402,255.00 in company stock.Percentage Held by Insiders11.55% of the stock of Oak Street Health is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions92.04% of the stock of Oak Street Health is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for Oak Street Health are expected to grow in the coming year, from ($1.58) to ($1.12) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Oak Street Health is -17.65, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Oak Street Health is -17.65, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Previous Next See Top Rated MarketRank™ Stocks Here About Oak Street Health (NYSE:OSH) StockOak Street Health, Inc., together with its subsidiaries, offers healthcare services to the patients in the United States. The company operates primary care centers for Medicare beneficiaries. As of December 31, 2021, it operated 129 centers in 19 states, including Illinois, Michigan, Pennsylvania, Ohio, and Texas. The company was founded in 2012 and is headquartered in Chicago, Illinois.Read More Receive OSH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Oak Street Health and its competitors with MarketBeat's FREE daily newsletter. Email Address OSH Stock News HeadlinesMay 31, 2023 | americanbankingnews.comOak Street Health, Inc. (NYSE:OSH) Receives $32.92 Average Price Target from AnalystsMay 6, 2023 | americanbankingnews.comHead to Head Contrast: GeneDx (NASDAQ:WGS) versus Oak Street Health (NYSE:OSH)June 2, 2023 | Edge On The Street (Ad)Is Graphite the New Lithium?Did you know that graphite (NOT lithium) is the largest component of lithium batteries used for EV's? Unfortunately, there are no graphite-producing mines in North America today. This leaves the U.S. at the mercy of China for our vital graphite supply.May 6, 2023 | americanbankingnews.comOak Street Health, Inc. (NYSE:OSH) Receives $32.92 Consensus Target Price from BrokeragesApril 29, 2023 | americanbankingnews.comComparing DocGo (NASDAQ:DCGO) and Oak Street Health (NYSE:OSH)April 21, 2023 | americanbankingnews.comOak Street Health, Inc. (NYSE:OSH) Insider Geoffrey M. Price Sells 50,000 SharesApril 19, 2023 | finance.yahoo.comWhat You Can Learn From Oak Street Health, Inc.'s (NYSE:OSH) P/SApril 18, 2023 | americanbankingnews.comReviewing DocGo (NASDAQ:DCGO) & Oak Street Health (NYSE:OSH)June 2, 2023 | Edge On The Street (Ad)The Graphite Shortage Story You're Not Being ToldGraphite demand for EV batteries is expected to increase 10X from 2020 to 2030. And today, with NO graphite-producing mines in N. America, China has a stranglehold on our graphite supply. That's why the U.S. government is spending billions of dollars to ensure an adequate domestic supply of this metal that's vital for energy independence and national security. April 14, 2023 | americanbankingnews.comOak Street Health (NYSE:OSH) Sets New 1-Year High at $38.87April 14, 2023 | americanbankingnews.comCritical Comparison: Oak Street Health (NYSE:OSH) versus DocGo (NASDAQ:DCGO)April 13, 2023 | americanbankingnews.comOak Street Health, Inc. (NYSE:OSH) Insider Sells $175,349.94 in StockApril 13, 2023 | americanbankingnews.comOak Street Health, Inc. (NYSE:OSH) CFO Timothy M. Cook Sells 5,978 Shares of StockApril 11, 2023 | americanbankingnews.comOak Street Health, Inc. (NYSE:OSH) Receives $32.92 Average Target Price from AnalystsApril 7, 2023 | americanbankingnews.comOak Street Health, Inc. (NYSE:OSH) Insider Sells $1,940,000.00 in StockApril 6, 2023 | marketwatch.comSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates HSKA, OSH, MLVFApril 6, 2023 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Acelrx (ACRX) and Oak Street Health (OSH)April 6, 2023 | americanbankingnews.comOak Street Health, Inc. (NYSE:OSH) Insider Sells $17,410,500.00 in StockApril 2, 2023 | seekingalpha.comCVS And Oak Street: The Pros And Cons Of A Deal That Felt InevitableMarch 30, 2023 | finance.yahoo.comOak Street Health Announces Cancellation of its 2023 Annual Meeting of StockholdersMarch 25, 2023 | americanbankingnews.comOak Street Health, Inc. (NYSE:OSH) Insider Sells $1,786,500.00 in StockMarch 22, 2023 | msn.comOak Street Health ticks lower as Sen. Warren urges FTC to probe CVS dealMarch 22, 2023 | finance.yahoo.comUPDATE 1-US Senator Warren urges FTC to review CVS-Oak Street deals - Bloomberg NewsMarch 21, 2023 | finance.yahoo.com4 big analyst cuts: Oak Street Health, ElectraMeccanica Vehicles | Pro RecapMarch 21, 2023 | americanbankingnews.comOak Street Health (NYSE:OSH) Downgraded by Wolfe Research to "Market Perform"March 15, 2023 | msn.comTD Cowen Downgrades Oak Street Health (OSH)March 15, 2023 | msn.comWhat 10 Analyst Ratings Have To Say About Oak Street HealthSee More Headlines OSH Company Calendar Last Earnings2/28/2023Today6/02/2023Next Earnings (Estimated)7/31/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE Industry Health services Sub-IndustryN/A SectorMedical Current SymbolNYSE:OSH CUSIPN/A CIK1564406 Webwww.oakstreethealth.com Phone844-871-5650FaxN/AEmployees6,000Year Founded2012Price Target and Rating Average Stock Price Forecast$33.27 High Stock Price Forecast$39.00 Low Stock Price Forecast$18.00 Consensus RatingHold Rating Score (0-4)2.06 Research Coverage17 Analysts Profitability EPS (Most Recent Fiscal Year)($2.21) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-509,200,000.00 Net Margins-23.57% Pretax Margin-23.58% Return on EquityN/A Return on Assets-25.08% Debt Debt-to-Equity RatioN/A Current Ratio1.41 Quick Ratio1.41 Sales & Book Value Annual Sales$2.16 billion Price / Sales0.00 Cash FlowN/A Price / Cash FlowN/A Book Value($1.10) per share Price / BookN/AMiscellaneous Outstanding Shares243,999,000Free Float215,817,000Market Cap$9.52 billion OptionableNot Optionable Beta2.23 Social Links Key ExecutivesMr. Michael T. Pykosz (Age 41)CEO & Chairman Comp: $886.49kMr. Geoffrey M. Price (Age 41)Chief Innovation Officer & Director Comp: $789.58kMr. Timothy M. CookChief Financial OfficerMr. Brian Clem (Age 40)Chief Operating Officer Comp: $587.25kMr. Robert Guenthner (Age 51)Chief Legal Officer & Sec. Comp: $492.62kMurali BalakumarChief Information OfficerMs. Sarah CluckHead of Investor RelationsMs. Erica FrankVP of PRMs. Cynthia Hiskes (Age 54)Chief HR Officer Dr. Griffin R. Myers M.D. (Age 42)Chief Medical Officer of Provider Engagement & Director More ExecutivesKey CompetitorsLifeStance Health GroupNASDAQ:LFSTPrivia Health GroupNASDAQ:PRVAPrometheus BiosciencesNASDAQ:RXDXUnited TherapeuticsNASDAQ:UTHRRepligenNASDAQ:RGENView All CompetitorsInsiders & InstitutionsJPMorgan Chase & Co.Bought 64,600 shares on 5/18/2023Ownership: 0.000%First Trust Advisors LPSold 21,230 shares on 5/16/2023Ownership: 0.051%Graham Capital Management L.P.Sold 18,213 shares on 5/16/2023Ownership: 0.026%Alberta Investment Management CorpBought 42,720 shares on 5/16/2023Ownership: 0.018%Squarepoint Ops LLCBought 8,799 shares on 5/16/2023Ownership: 0.004%View All Insider TransactionsView All Institutional Transactions OSH Stock - Frequently Asked Questions Should I buy or sell Oak Street Health stock right now? 17 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Oak Street Health in the last twelve months. There are currently 1 sell rating, 14 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" OSH shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in OSH, but not buy additional shares or sell existing shares. View OSH analyst ratings or view top-rated stocks. What is Oak Street Health's stock price forecast for 2023? 17 brokers have issued 1-year target prices for Oak Street Health's shares. Their OSH share price forecasts range from $18.00 to $39.00. On average, they predict the company's share price to reach $33.27 in the next twelve months. View analysts price targets for OSH or view top-rated stocks among Wall Street analysts. When is Oak Street Health's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Monday, July 31st 2023. View our OSH earnings forecast. How were Oak Street Health's earnings last quarter? Oak Street Health, Inc. (NYSE:OSH) released its earnings results on Tuesday, February, 28th. The company reported ($0.56) EPS for the quarter, beating analysts' consensus estimates of ($0.58) by $0.02. The company had revenue of $577.70 million for the quarter, compared to analyst estimates of $571.26 million. The company's revenue was up 46.6% on a year-over-year basis. During the same quarter in the previous year, the company posted ($0.62) EPS. What ETFs hold Oak Street Health's stock? ETFs with the largest weight of Oak Street Health (NYSE:OSH) stock in their portfolio include IQ Merger Arbitrage ETF (MNA), AltShares Merger Arbitrage ETF (ARB), ProShares Merger ETF (MRGR), SPDR S&P Health Care Services ETF (XHS), Renaissance IPO ETF (IPO), AltShares Event-Driven ET (EVNT), iShares U.S. Healthcare Providers ETF (IHF) and Fidelity Growth Opportunities ETF (FGRO). What is Peter Botten's approval rating as Oak Street Health's CEO? 17 employees have rated Oak Street Health Chief Executive Officer Peter Botten on Glassdoor.com. Peter Botten has an approval rating of 71% among the company's employees. What other stocks do shareholders of Oak Street Health own? Based on aggregate information from My MarketBeat watchlists, some companies that other Oak Street Health investors own include Alibaba Group (BABA), Tesla (TSLA), Adobe (ADBE), NVIDIA (NVDA), Okta (OKTA), Zoom Video Communications (ZM), Autodesk (ADSK), Boeing (BA), Lockheed Martin (LMT) and Micron Technology (MU). When did Oak Street Health IPO? (OSH) raised $250 million in an initial public offering (IPO) on Thursday, August 6th 2020. The company issued 15,600,000 shares at a price of $15.00-$17.00 per share. J.P. Morgan, Goldman Sachs and Morgan Stanley acted as the underwriters for the IPO and William Blair, Piper Sandler, Baird and SunTrust Robinson Humphrey were co-managers. What is Oak Street Health's stock symbol? Oak Street Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "OSH." Who are Oak Street Health's major shareholders? Oak Street Health's stock is owned by many different institutional and retail investors. Top institutional investors include Farallon Capital Management LLC (1.85%), Route One Investment Company L.P. (0.79%), Geode Capital Management LLC (0.66%), Davidson Kempner Capital Management LP (0.65%), Schonfeld Strategic Advisors LLC (0.60%) and Glazer Capital LLC (0.54%). Insiders that own company stock include Brian Clem, General Atlantic Llc, Geoffrey M Price, Geoffrey M Price, Griffin Myers, Kim Keck, Michael Robert Martin, Michael T Pykosz, Michael T Pykosz, Newlight Partners Lp, Robert Guenthner, Shawn Henry and Timothy M Cook. View institutional ownership trends. How do I buy shares of Oak Street Health? Shares of OSH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. How much money does Oak Street Health make? Oak Street Health (NYSE:OSH) has a market capitalization of $0.00 and generates $2.16 billion in revenue each year. The company earns $-509,200,000.00 in net income (profit) each year or ($2.21) on an earnings per share basis. How many employees does Oak Street Health have? The company employs 6,000 workers across the globe. Does Oak Street Health have any subsidiaries? The following companies are subsidiares of Oak Street Health: Acorn Network LLC, Oak Street Health Mso LLC, and RubiconMD.Read More How can I contact Oak Street Health? Oak Street Health's mailing address is 30 W. MONROE ST. STE. 1200, CHICAGO IL, 60603. The official website for the company is www.oakstreethealth.com. The company can be reached via phone at 844-871-5650 or via email at investors@oakstreethealth.com. This page (NYSE:OSH) was last updated on 6/2/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Oak Street Health, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.